SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Chapter 25 The pharmaceutical industry
16 references·2 citing·35 second hop
Chapter 25 The pharmaceutical industry (2000)Chapter 25 The pharmaceutical industryScience and Engineering Indicators 1998 (1998)Science and Engineering Indic…Absorptive Capacity, Coauthoring Behavior, and the Organization of Research in Drug Discovery (1998)Absorptive Capacity, Coauthor…Generic Entry and the Pricing of Pharmaceuticals (1997)Generic Entry and the Pricing…Scale, Scope, and Spillovers: The Determinants of Research Productivity in Drug Discovery (1996)Scale, Scope, and Spillovers:…Free for All? Lessons from the RAND Health Insurance Experiment (1995)Free for All? Lessons from th…Academic Research Underlying Industrial Innovations: Sources, Characteristics, and Financing (1995)Academic Research Underlying …Free for all?: lessons from the Rand Health Insurance Experiment (1994)Free for all?: lessons from t…Welfare Effects of Global Patent Protection (1992)Welfare Effects of Global Pat…Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act (1992)Brand Loyalty, Entry, and Pri…Patent Expiration, Entry, and Competition in the U.S. Pharmaceutical Industry (1991)Patent Expiration, Entry, and…Effects of Medicaid Drug-Payment Limits on Admission to Hospitals and Nursing Homes (1991)Effects of Medicaid Drug-Paym…Cost of innovation in the pharmaceutical industry (1991)Cost of innovation in the pha…Industrial market structure and economic performance (1990)Industrial market structure a…Appropriating the Returns from Industrial Research and Development (1987)Appropriating the Returns fro…Optimal Advertising and Optimal Quality (1976)Optimal Advertising and Optim…Industrial Market Structure and Economic Performance. (1971)Industrial Market Structure a…The simple economics of risk-sharing agreements between the NHS and the pharmaceutical industry (2010)The simple economics of risk-…Managed care's price bargaining with hospitals (2008)Managed care's price bargaini…Innovation and Learning: The Two Faces of R & D (1989)Measuring Competence? Exploring Firm Effects in Pharmaceutical Research (1994)Is public R&D a complement or substitute for private R&D? A review of the econometric evidence (2000)The Network Structure Of Social Capital (2000)PERSPECTIVE—Absorbing the Concept of Absorptive Capacity: How to Realize Its Potential in the Organization Field (2010)Conditional logit analysis of qualitative choice behavior (1972)Qualitative Response Models: A Survey (1994)Sources and Financial Consequences of Radical Innovation: Insights from Pharmaceuticals (2003)The cost of biopharmaceutical R&D: is biotech different? (2007)Essential medicines for universal health coverage (2016)Real Effects of Academic Research (1989)Geographic Localization of Knowledge Spillovers as Evidenced by Patent Citations (1993)Academic research and industrial innovation: An update of empirical findings (1998)The New Economics Of Innovation, Spillovers And Agglomeration: Areview Of Empirical Studies (1999)Chapter 61 Knowledge spillovers and the geography of innovation (2004)The Sources of Innovation (2007)Asset Stock Accumulation and Sustainability of Competitive Advantage (1989)Does it pay to be different? An analysis of the relationship between corporate social and financial performance (2008)Corporate social responsibility and access to finance (2013)A review of research on teacher beliefs and practices (1996)The Knowledge Economy (2004)Active learning increases student performance in science, engineering, and mathematics (2014)Adverse Events Associated With Prescription Drug Cost-Sharing Among Poor and Elderly Persons (2001)The Impact of Nearly Universal Insurance Coverage on Health Care Utilization: Evidence from Medicare (2008)Medical Bankruptcy in the United States, 2007: Results of a National Study (2009)Innovation in cities: (1999)Aging, Obsolescence, and Organizational Innovation (2000)Innovation, growth and survival (1995)When do firms learn from their acquisition experience? Evidence from 1990 to 1995 (2001)Fifty Years of Empirical Studies of Innovative Activity and Performance (2010)Market Size in Innovation: Theory and Evidence from the Pharmaceutical Industry (2004)The Burden of Knowledge and the “Death of the Renaissance Man”: Is Innovation Getting Harder? (2008)Sectoral patterns of technical change: Towards a taxonomy and a theory (1984)First-mover advantages (1988)Sources, Procedures, and Microeconomic Effects of Innovation (2000)
this work references cited by second hop

References

  • 1971Industrial Market Structure and Economic Performance.6,267 cited
  • 1987Appropriating the Returns from Industrial Research and Development3,771 cited
  • 1990Industrial market structure and economic performance2,573 cited
  • 1996Scale, Scope, and Spillovers: The Determinants of Research Productivity in Drug Discovery1,389 cited
  • 1998Science and Engineering Indicators 19981,327 cited
  • 1998Absorptive Capacity, Coauthoring Behavior, and the Organization of Research in Drug Discovery1,199 cited
  • 1995Academic Research Underlying Industrial Innovations: Sources, Characteristics, and Financing1,031 cited
  • 1995Free for All? Lessons from the RAND Health Insurance Experiment991 cited
  • 1991Cost of innovation in the pharmaceutical industry763 cited
  • 1976Optimal Advertising and Optimal Quality724 cited
  • 1994Free for all?: lessons from the Rand Health Insurance Experiment584 cited
  • 1992Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act574 cited
  • 1991Effects of Medicaid Drug-Payment Limits on Admission to Hospitals and Nursing Homes505 cited
  • 1992Welfare Effects of Global Patent Protection422 cited
  • 1991Patent Expiration, Entry, and Competition in the U.S. Pharmaceutical Industry

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

399 cited
  • 1997Generic Entry and the Pricing of Pharmaceuticals388 cited
  • Cited by

    • 2008Managed care's price bargaining with hospitals72 cited
    • 2010The simple economics of risk-sharing agreements between the NHS and the pharmaceutical industry68 cited